The SOCS box: A tale of destruction and degradation

Trends in Biochemical Sciences

Volumn 27, Issue 5, 2002, Pages 235-241

  Kile, Benjamin T ^a   Schulman, Brenda A ^c   Alexander, Warren S ^a   Nicola, Nicos A ^a   Martin, Helene M E ^a   Hilton, Douglas J ^b  

^a Department of Civil and Environmental Engineering   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ISOPROTEIN; JANUS KINASE; LEUCINE; PROTEASOME; PROTEIN; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; CARRIER PROTEIN; LIGASE; REPRESSOR PROTEIN; SIGNAL PEPTIDE; SOCS1 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CHEMICAL REACTION; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; NONHUMAN; POLYUBIQUITINATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMAL; CARRIER PROTEINS; CYTOKINES; LIGASES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; REPRESSOR PROTEINS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UBIQUITIN-PROTEIN LIGASES;

JANUS;

EID: 0036558025     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(02)02085-6     Document Type: Review

References (60)

1. Signaling by the cytokine receptor superfamily: JAKs and STATs
2. The role of phosphatases in lymphocyte activation
3. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
4. Specific inhibition of Stat3 signal transduction by PIAS3
5. Negative regulators of cytokine signal transduction
6. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors
7. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine
8. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality
9. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice
10. SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-γ and IL-4 signaling in vivo
11. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1
12. Lack of Socs2 expression causes the high-growth phenotype in mice
13. Gigantism in mice lacking suppressor of cytokine signalling-2
14. SOCS3 is essential in the regulation of fetal liver erythropoiesis
15. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3
16. JAKs and STATs in invertebrate model organisms
17. Identification of the first invertebrate interleukin JAK/STAT receptor, the Drosophila gene domeless
18. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance
19. Functional analysis of Asb-1 using genetic modification in mice
20. SWiP-1: Novel SOCS box containing WD-protein regulated by signalling centres and by Shh during development
21. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation
22. The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, Ras, WD-40 repeat, and ankyrin repeat families
23. RNA polymerase II transcription factor SIII. I. Identification, purification, and properties
24. Elongin (SIII): A multisubunit regulator of elongation by RNA polymerase II
25. Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C
26. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer
27. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene
28. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein
29. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
30. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex
31. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins
32. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity
33. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein
34. 2 sensing
35. Structure of the VHL-elongin C-elongin B complex: Implications for VHL tumor suppressor function
36. Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation
37. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
38. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction
39. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
40. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130
41. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985
42. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins
43. Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation
44. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells
45. Socs-1 inhibits TEK-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation
46. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1
47. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors
48. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation
49. Cellular proteins that bind the von Hippel-Lindau disease gene product: Mapping of binding domains and the effect of missense mutations
50. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signalling
51. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo
52. Setting the standards: Quality control in the secretory pathway
53. Drosophila Neuralized is a ubiquitin ligase that promotes the internalization and degradation of Delta
54. Xenopus Neuralized is a ubiquitin ligase that interacts with XDelta1 and regulates Notch signaling
55. Identification of a human homolog of the Drosophila Neuralized gene within the 10q25.1 malignant astrocytoma deletion region
56. The von Hippel-Lindau tumor suppressor protein
57. Combinatorial control in ubiquitin-dependent proteolysis: Don't Skp the F-box hypothesis
58. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
59. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex
60. The ubiquitin system